Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following Surgery
Clinical trial NCT05315479 · TERMINATED
Trial details
- NCT number
- NCT05315479
- Sponsor
- Baudax Bio
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-24
- Primary completion
- 2022-07-07
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.